Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral Ulodesine Added to Allopurinol

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01265264
Recruitment Status : Completed
First Posted : December 23, 2010
Last Update Posted : November 20, 2013
Information provided by (Responsible Party):
BioCryst Pharmaceuticals

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2012
  Actual Study Completion Date : February 2013
  Certification/Extension First Submitted : October 4, 2013